Cargando…
Intensity of antiplatelet therapy and percutaneous coronary intervention
Thienopyridine derivatives such as clopidogrel have been shown to reduce the incidence of death in patients undergoing percutaneous coronary intervention when used in conjunction with aspirin. Recently, a new thienopyridine, prasugrel, significantly reduced the primary endpoint of cardiovascular dea...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medicine Reports Ltd
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920701/ https://www.ncbi.nlm.nih.gov/pubmed/20948699 http://dx.doi.org/10.3410/M1-8 |